Skip to main content
PLOS One logoLink to PLOS One
. 2024 Jul 24;19(7):e0307702. doi: 10.1371/journal.pone.0307702

The association between alcohol consumption and herpes simplex virus type 2: A cross-sectional study from national health and nutrition examination survey 2009–2016

Yushan Shi 1,2,#, Jiafeng Zhang 3,#, Zhantong Wang 4,#, Feng Shan 1,*
Editor: Tinashe Mudzviti5
PMCID: PMC11268616  PMID: 39047002

Abstract

Background

The current prevalence of Herpes simplex virus type 2 (HSV-2) infection is notably high, with individuals afflicted by HSV-2 facing recurrent outbreaks, challenges in achieving remission, and an elevated risk of HIV infection. This study aims to investigate the relationship between alcohol consumption and HSV-2 infection.

Methods

The data for this study were sourced from 7257 participants who took part in the National Health and Nutrition Examination Survey (NHANES) from 2009 to 2016. The target population consisted of adults with reliable HSV-2 plasma results, and alcohol consumption was assessed using self-report methods. We evaluated the odds ratio (OR) and 95% confidence interval (CI) for the association between alcohol consumption and HSV-2 infection. These estimations were derived from a logistic regression model that was adjusted for key confounding factors. Subgroup analysis specifically focused on alcohol consumption, and the interaction between HSV-2 infection, alcohol consumption, and other variables was assessed through stratified analysis.

Results

Among the 7,257 participants included, 89.8% (6,518/7,257) reported varying levels of alcohol consumption history. Compared to individuals who never drinkers, the adjusted odds ratios (ORs) for former drinkers, light drinkers, moderate drinkers, and heavy drinkers were 1.79 (95% CI: 1.34–2.4, p < 0.001), 1.38 (95% CI: 1.07–1.77, p = 0.012), 1.49 (95% CI: 1.15–1.94, p = 0.003), and 1.47 (95% CI: 1.14–1.9, p = 0.003), respectively. The results remained stable in subgroup analyses and sensitivity analyses.

Conclusion

Current research indicates that individuals with a history of alcohol consumption exhibit a higher risk of HSV-2 infection compared to those who have never drinkers.

1. Introduction

Herpes Simplex Virus type 2 (HSV-2) is the primary causative agent of genital herpes, a ulcerative condition characterized by recurrent, lingering outbreaks and an increased risk of HIV infection [1]. The prevalence of HSV-2 varies across different countries and regions, exhibiting a rising trend. The World Health Organization (WHO) estimates that over 500 million individuals aged 15–49 globally are infected with HSV-2, with an annual increment of 24 million new cases [2, 3]. HSV-2 is primarily transmitted through sexual contact, via exposure to infected genitalia or bodily fluids, underscoring the impact of lifestyle factors on this mode of transmission. Hence, investigating the influence of lifestyle factors related to HSV infection is crucial [4].

Alcohol consumption, a common behavior in various lifestyles, has been shown to significantly affect life expectancy and contribute to the global disease and mortality burden, potentially becoming the third-largest modifiable risk factor for death and disability worldwide [5]. While moderate drinking is considered beneficial for certain diseases, other studies report no benefits [6]. The relationship between alcohol consumption and HSV-2 infection in a representative American population remains unclear.

Using data from the National Health and Nutrition Examination Survey (NHANES), this study evaluates the relationship between different alcohol consumption statuses and HSV-2 infection, aiming to fill this knowledge gap. We detailed alcohol intake levels and analyzed the association between different drinking statuses and HSV-2. Additionally, we explored whether these associations varied by age, gender, ethnicity, and other covariates. The insights gathered could enhance the broader understanding of the impact of lifestyle factors, particularly alcohol consumption, on HSV-2 transmission.

2. Methods

2.1 Study design and participants

This cross-sectional study utilized data from 4 consecutive cycles of the NHANES spanning from 2009 to 2016. The NHANES was authorized by the Ethical Review Committee of the National Center for Health Statistics, and all participants provided written informed consent. The research reported here employed publicly available and de-identified data; thus, it was exempt from review and the requirement of informed consent. This study adhered to the STROBE (Strengthening the Reporting of Observational studies in Epidemiology) reporting guidelines [7].

The NHANES is a cross-sectional survey that utilizes stratified, multi-stage random sampling techniques to collect data from a nationally representative sample of non-institutionalized citizens of the United States. Among 40439 participants, we excluded individuals for 1) missing HSV-2 data (n = 28612), 2) absence of alcohol consumption data (n = 1528), and 3) missing data for potential covariates, including marital status (n = 767), ratio of family income to poverty (PIR) (n = 692), education level (n = 5), body mass index (BMI) (n = 44), health insurance coverage (n = 7), smoking status (n = 5), frequency of condom use (n = 1,312), diabetes (n = 180), hypertension (n = 1), chronic kidney disease (CKD) (n = 28), and chronic obstructive pulmonary disease (COPD) (n = 1). (Fig 1).

Fig 1. The study’s flow diagram.

Fig 1

Abbreviations: HSV, herpes simplex virus; NHANES, National Health and Nutrition Examination Survey.

2.2 Alcohol consumption

Trained interviewers used the Computer-Assisted Personal Interviewing (CAPI) system to inquire about alcohol intake. Based on the self-reported responses from these questionnaires, participants were categorized into 5 alcohol consumption as described in previous studies [8, 9].

Participants were categorized into distinct alcohol consumption groups based on their drinking patterns: 1) never drinkers (consumed less than 12 alcoholic beverages in their lifetime); 2) Former drinkers (consumed 12 or more alcoholic beverages in a year but abstained last year, or abstained last year but had a lifetime consumption of 12 or more drinks); 3) light drinkers (up to 1 drink per day for women and up to 2 drinks per day for men on average over the past year); 4) moderate drinkers (up to 2 drinks daily for women and up to 3 for men); 5) heavy drinkers (3 or more drinks daily for women, 4 or more for men).

2.3 Definition of HSV-2

Participants provided serum samples at the time of the survey, which were stored under appropriate frozen conditions (-30°C) and sent to a Clinical Laboratory Improvement Amendments (CLIA) certified laboratory. A complete summary of the laboratory methods is available on the NHANES website.

Through the use of monoclonal antibodies and affinity chromatography, a specific glycoprotein known as gG-2 is purified from HSV-2. The solid-phase enzymatic immune dot assay is then employed to detect antibodies reactive to the gG-2 antigen in the serum.

2.4 Study covariates

In this study, the covariates considered included age, gender, self-reported race and ethnicity (categories being Mexican American, non-Hispanic Black, non-Hispanic White, and others), marital status (either living alone or married/living with a partner), educational attainment (categorized as less than high school, high school or GED equivalent, and above high school), PIR (≤1.3, 1.3–3.5, and >3.5), BMI (<25 and ≥25), health insurance coverage (yes or no), smoking status (never, former, or current smoker), frequency of condom use (never, less than half the time, about half the time, more than half the time, always). The frequency of condom use was determined based on responses to variable SXQ251.

Diabetes was defined as a fasting blood glucose level ≥7 mmol/L, a medical diagnosis of diabetes by a physician, use of oral hypoglycemic agents or insulin, or a glycated hemoglobin (HbA1c) level ≥6.5% [10]. Hypertension was defined as having a systolic blood pressure of >130 mmHg or a diastolic blood pressure of >80 mmHg, averaged over three measurements, or a history of high blood pressure or oral antihypertensive medication use [11]. CKD was defined based on an eGFR lower than 60 ml/min/1.73m^2 or a urine albumin-to-creatinine ratio of 30 mg/g or higher, in line with the KDIGO 2021 guidelines for Glomerular Diseases [12]. COPD criteria included: 1) A FEV1/FVC ratio below 0.7; 2) A previous diagnosis of emphysema; 3) Being over 40 years old, with a smoking history or chronic bronchitis, and the use of specific medications such as phosphodiesterase-4 inhibitors [13]. Cardiovascular Disease (CVD) and cancer were considered present if participants were informed by a physician of having such conditions.

2.5 Statistical analyses

Data analysis was conducted from October 1 to December 31, 2023. Considering the complex sampling methods of NHANES. Baseline characteristics for each alcohol consumption category were compared using the chi-square test for categorical variables and analysis of variance for continuous variables. Logistic regression models were employed to determine the odds ratios (OR) and 95% confidence intervals (95% CI) for the association between alcohol consumption and HSV-2. Model 1 was adjusted for age, gender, race/ethnicity, marital status, and education level; Model 2 additionally adjusted for PIR, smoking status, frequency of condom use, while Model 3 included adjustments for all the variables incorporated.

In the subgroup analyses, we replicated the primary analyses, stratifying alcohol consumption by sex, age (<31 years vs ≥31 years), marital status, PIR (low vs medium or high), diabetes (yes vs no), hypertension (yes vs no).

In the sensitivity analyses, we categorized alcohol consumption into never drinkers and drinkers, and conducted sensitivity analyses across the previously described 3 models.

Statistical analyses were conducted using R software (version 4.2.2, R Foundation for Statistical Computing) and Free Statistics software version 1.8. All hypothesis tests were two-sided, with a P-value of less than 0.05 considered to indicate statistical significance.

3. Results

3.1 Study population characteristics

The analytic sample comprised 7257 participants (mean [SD] age 34.5 [8.5] years; 3643 women [50.2%] and 3614 men [49.8%]; 1131 Mexican Americans [15.6%], 1414 Black [19.5%], 3033 White [41.8%], and 1679 of other races and ethnicities [23.1%]). The positivity individuals for HSV-2 was 1464 (20.2%). Detailed participant demographics stratified by alcohol consumption are presented in Table 1. 10.2% (739) of participants were never drinkers, 9.2% (665) were former drinkers, 30.1% (2183) were light drinkers, 19.9% (1445) were moderate drinkers, and 30.7% (2225) were heavy drinkers. Statistical significant differences were observed in baseline parameters across the five alcohol consumption groups. Compared to other groups, former drinkers had the highest proportion of HSV-2 positivity (26.2%). Relative to never drinkers, heavy drinkers had a higher proportion of males, a higher frequency of smoking, and higher rates of hypertension, CKD, COPD, CVD, and cancer.

Table 1. Baseline demographic characteristics of the participants according to alcohol consumption.

Variables Total
(n = 7257)
Never drinkers
(n = 739)
Former drinkers
(n = 665)
Light drinkers
(n = 2183)
Moderate drinkers
(n = 1445)
Heavy drinkers (n = 2225) p
Age(years) 34.5 ± 8.5 35.0 ± 8.6 37.3 ± 8.1 35.5 ± 8.3 34.5 ± 8.5 32.7 ± 8.6 < 0.001
Age(years), n (%) < 0.001
 18–24 1173 (16.2) 112 (15.2) 61 (9.2) 271 (12.4) 221 (15.3) 508 (22.8)
 25–30 1444 (19.9) 138 (18.7) 84 (12.6) 388 (17.8) 309 (21.4) 525 (23.6)
 31–40 2469 (34.0) 258 (34.9) 251 (37.7) 798 (36.6) 485 (33.6) 677 (30.4)
 41–49 2171 (29.9) 231 (31.3) 269 (40.5) 726 (33.3) 430 (29.8) 515 (23.1)
Gender, n (%) < 0.001
 Female 3643 (50.2) 504 (68.2) 339 (51) 936 (42.9) 909 (62.9) 955 (42.9)
 Male 3614 (49.8) 235 (31.8) 326 (49) 1247 (57.1) 536 (37.1) 1270 (57.1)
Race/Ethnicity, n (%) < 0.001
 Mexican American 1131 (15.6) 143 (19.4) 110 (16.5) 222 (10.2) 194 (13.4) 462 (20.8)
 Non-Hispanic black 1414 (19.5) 175 (23.7) 97 (14.6) 496 (22.7) 309 (21.4) 337 (15.1)
 Non-Hispanic white 3033 (41.8) 191 (25.8) 302 (45.4) 899 (41.2) 652 (45.1) 989 (44.4)
 Others 1679 (23.1) 230 (31.1) 156 (23.5) 566 (25.9) 290 (20.1) 437 (19.6)
Marital status, n (%) < 0.001
 Living alone 2592 (35.7) 177 (24) 149 (22.4) 654 (30) 558 (38.6) 1054 (47.4)
 Married or living with a partner 4665 (64.3) 562 (76) 516 (77.6) 1529 (70) 887 (61.4) 1171 (52.6)
Education level, n (%) < 0.001
 Less than high school 1236 (17.0) 160 (21.7) 159 (23.9) 233 (10.7) 186 (12.9) 498 (22.4)
 High school or GED 1564 (21.6) 157 (21.2) 173 (26) 368 (16.9) 281 (19.4) 585 (26.3)
 Above high school 4457 (61.4) 422 (57.1) 333 (50.1) 1582 (72.5) 978 (67.7) 1142 (51.3)
PIR, n (%) < 0.001
 ≤1.3 2469 (34.0) 323 (43.7) 295 (44.4) 577 (26.4) 412 (28.5) 862 (38.7)
 1.3–3.5 2603 (35.9) 249 (33.7) 236 (35.5) 759 (34.8) 532 (36.8) 827 (37.2)
 >3.5 2185 (30.1) 167 (22.6) 134 (20.2) 847 (38.8) 501 (34.7) 536 (24.1)
BMI(Kg/m2) < 0.001
 <25 2378 (32.8) 228 (30.9) 170 (25.6) 784 (35.9) 500 (34.6) 696 (31.3)
 ≥25 4879 (67.2) 511 (69.1) 495 (74.4) 1399 (64.1) 945 (65.4) 1529 (68.7)
Health Insurance Coverage, n (%) < 0.001
 No 2157 (29.7) 236 (31.9) 201 (30.2) 491 (22.5) 376 (26) 853 (38.3)
 Yes 5100 (70.3) 503 (68.1) 464 (69.8) 1692 (77.5) 1069 (74) 1372 (61.7)
Smoking status, n (%) < 0.001
 Never 4350 (59.9) 658 (89) 369 (55.5) 1497 (68.6) 844 (58.4) 982 (44.1)
 Former 1104 (15.2) 25 (3.4) 133 (20) 334 (15.3) 259 (17.9) 353 (15.9)
 Current 1803 (24.8) 56 (7.6) 163 (24.5) 352 (16.1) 342 (23.7) 890 (40)
Frequency of Condom Use, n (%) < 0.001
 Never 1737 (23.9) 229 (31) 165 (24.8) 499 (22.9) 328 (22.7) 516 (23.2)
 Less than half of time 1052 (14.5) 107 (14.5) 70 (10.5) 313 (14.3) 198 (13.7) 364 (16.4)
 About half of time 495 (6.8) 35 (4.7) 40 (6) 134 (6.1) 89 (6.2) 197 (8.9)
 More than half of time 681 (9.4) 56 (7.6) 57 (8.6) 172 (7.9) 165 (11.4) 231 (10.4)
 Always 3292 (45.4) 312 (42.2) 333 (50.1) 1065 (48.8) 665 (46) 917 (41.2)
Diabetes, n (%) < 0.001
 No 6908 (95.2) 696 (94.2) 610 (91.7) 2078 (95.2) 1386 (95.9) 2138 (96.1)
 Yes 349 (4.8) 43 (5.8) 55 (8.3) 105 (4.8) 59 (4.1) 87 (3.9)
Hypertension, n (%) < 0.001
 No 5696 (78.5) 601 (81.3) 483 (72.6) 1725 (79) 1154 (79.9) 1733 (77.9)
 Yes 1561 (21.5) 138 (18.7) 182 (27.4) 458 (21) 291 (20.1) 492 (22.1)
CKD, n (%) 0.256
 No 6769 (93.3) 689 (93.2) 609 (91.6) 2053 (94) 1348 (93.3) 2070 (93)
 Yes 488 (6.7) 50 (6.8) 56 (8.4) 130 (6) 97 (6.7) 155 (7)
COPD, n (%) 0.118
 No 7138 (98.4) 733 (99.2) 651 (97.9) 2150 (98.5) 1425 (98.6) 2179 (97.9)
 Yes 119 (1.6) 6 (0.8) 14 (2.1) 33 (1.5) 20 (1.4) 46 (2.1)
CVD, n (%) < 0.001
 No 7073 (97.5) 728 (98.5) 633 (95.2) 2134 (97.8) 1415 (97.9) 2163 (97.2)
 Yes 184 (2.5) 11 (1.5) 32 (4.8) 49 (2.2) 30 (2.1) 62 (2.8)
Cancer, n (%) 0.331
 No 7065 (97.4) 725 (98.1) 647 (97.3) 2130 (97.6) 1397 (96.7) 2166 (97.3)
 Yes 192 (2.6) 14 (1.9) 18 (2.7) 53 (2.4) 48 (3.3) 59 (2.7)
HSV-2, n (%) < 0.001
 Negative 5793 (79.8) 611 (82.7) 491 (73.8) 1776 (81.4) 1123 (77.7) 1792 (80.5)
 Positive 1464 (20.2) 128 (17.3) 174 (26.2) 407 (18.6) 322 (22.3) 433 (19.5)

Abbreviations: PIR Ratio of family income to poverty, BMI Body mass index, CKD Chronic kidney disease, CVD Cardiovascular disease, COPD Chronic obstructive pulmonary disease, HSV herpes simplex virus; IQR Interquartile Range.

Univariate analysis of all variables in Table 1 indicated that age, gender, marital status, PIR, BMI, health insurance, smoking status, and comorbidities are associated with HSV infection. (S1 Table in S1 File).

3.2 Relationship between alcohol consumption and HSV-2

In the expanded multivariate logistic regression models, we observed that the odds ratios (OR) for alcohol consumption were consistently significant across all three models (OR range 1.36–2.14, p < 0.05). Without adjusting any factors in the crude model, former drinkers and moderate drinkers exhibited a higher risk of HSV-2 infection (OR = 1.69, 95% CI: 1.31–2.19, p < 0.001; OR = 1.37, 95% CI: 1.09–1.72, p = 0.007). After adjustments for age, sex, race/ethnicity, marital status, and education level, alcohol consumption in all four statuses remained associated with an increased risk (OR range 1.42–2.14, p < 0.05). The results of the fully adjusted model 3 were consistent with earlier findings (OR range 1.38–1.79, p < 0.05). Across all three models, the highest risk of HSV-2 positivity was consistently observed in the former drinkers group compared to the never drinkers group, with OR ranging from 1.69 to 2.14 (p<0.001). (Table 2).

Table 2. Association between alcohol consumption and HSV-2.

Alcohol consumption Crude model Model 1 Model 2 Model 3
OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p
Never drinkers Ref Ref Ref Ref
Former drinkers 1.69 (1.31~2.19) <0.001 2.14 (1.61~2.85) <0.001 1.82 (1.36~2.44) <0.001 1.79 (1.34~2.4) <0.001
Light drinkers 1.09 (0.88~1.36) 0.421 1.42 (1.12~1.82) 0.005 1.36 (1.06~1.74) 0.016 1.38 (1.07~1.77) 0.012
Moderate drinkers 1.37 (1.09~1.72) 0.007 1.65 (1.28~2.13) <0.001 1.49 (1.15~1.93) 0.003 1.49 (1.15~1.94) 0.003
Heavy drinkers 1.15 (0.93~1.43) 0.198 1.84 (1.44~2.35) <0.001 1.49 (1.16~1.93) 0.002 1.47 (1.14~1.9) 0.003

Crude model adjusted for: none

Model 1 adjusted for: age, sex, race/ethnicity, marital status, education level

Model 2 adjusted for: age, sex, race/ethnicity, marital status, education level, PIR, smoking status, frequency of condom use

Model 3 adjusted for: all variables

In the subgroup analyses stratified by age group, gender, marital status, poverty income ratio, diabetes, and hypertension, the association between alcohol consumption and HSV-2 infection was consistent (Fig 2). This consistent association was also observed in other subgroups (S1 Fig in S1 File).

Fig 2. The relationship between alcohol consumption and HSV-2 according to basic features.

Fig 2

Except for the stratification component itself, each stratification factor was adjusted for all other variable.

In the sensitivity analyses, after categorizing alcohol consumption into two groups: never drinkers and drinkers, it was found that in the crude model, without adjusting for any variables, the risk of HSV-2 infection was higher in the drinking group (OR = 1.23, 95% CI: 1.01–1.5, p = 0.042). Across all three models, compared to never drinkers, the drinking group consistently showed a higher risk of HSV-2 infection (Table 3).

Table 3. Sensitivity analysis of the relationship between alcohol consumption and HSV-2 infection.

Alcohol consumption Crude model Model 1 Model 2 Model 3
OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p
Never drinkers Ref Ref Ref Ref
drinkers 1.23 (1.01~1.5) 0.042 1.68 (1.34~2.1) <0.001 1.48 (1.18~1.87) 0.001 1.48 (1.18~1.86) <0.001

Crude model adjusted for: none

Model 1 adjusted for: age, sex, race/ethnicity, marital status, education level

Model 2 adjusted for: age, sex, race/ethnicity, marital status, education level, PIR, smoking status, frequency of condom use

Model 3 adjusted for: all variables

4. Discussion

This cross-sectional study demonstrates an association between alcohol consumption and the risk of HSV-2 infection. In our multivariate logistic regression models, both former and current drinkers exhibited a higher risk of HSV-2 infection compared to individuals who have never consumed alcohol. Our findings consistently indicate that alcohol consumption, whether past or present, is a risk factor for HSV-2 infection.

The impact of alcohol consumption on HSV-2 infection has been documented in limited research. A study by Trong et al. suggests that reducing alcohol intake could effectively control HSV-2 infection among bar and hotel workers [14]. Similarly, research by Yasufumi et al. found that current male drinkers in Japan are more susceptible to HSV-2 infection compared to never drinkers [15]. Notably, these studies, conducted outside the United States, do not extensively investigate the influence of sexual behavior on the relationship between alcohol consumption and HSV-2 infection. Utilizing NHANES data, our study offers a unique opportunity to assess this association with comprehensive adjustments for a wide range of covariates, including sexual activity and frequency of condom use, through a series of stratified analyses.

While the underlying mechanisms of the association between alcohol consumption and HSV-2 remain to be further explored, our findings are biologically plausible based on existing evidence. Previous studies have shown that drinking can increase high-risk behaviors, thereby raising the risk of sexually transmitted diseases (STDs), whereas limiting or abstaining from alcohol can reduce such behaviors and lower the disease burden of STDs [16, 17]. Alcohol affects the neurotransmitter and neuroendocrine systems, leading to disruptions in emotional perception and cognitive functions, which could be the reason for the increase in risky behaviors following alcohol consumption [18, 19]. This, in turn, elevates the risk of HSV-2 infection. Furthermore, alcohol use, regardless of the amount, leads to health detriment in populations, and long-term drinking alters adaptive immunity and cytokine activity, affecting inflammatory responses [20, 21]. Moreover, studies have shown that chronic alcohol consumption can alter the transcriptome of bone marrow-derived monocytes, potentially impacting monocyte activity and their migration from the bone marrow, thereby affecting immune responses. Additionally, chronic alcohol intake can bias the differentiation of CD34+ progenitor cells in the bone marrow towards the granulocyte/monocyte lineage, leading to a decreased antigen-presenting capability of monocytes derived from CD34+ progenitor cells [22]. This alteration persists even after cessation of alcohol consumption and may compromise both immune and inflammatory responses. These impacts on the immune system and inflammatory responses could increase susceptibility to HSV-2, also explaining why former drinkers may still exhibit a heightened risk of HSV-2 infection.

Our study is subject to several limitations that warrant consideration, which may affect the interpretation and generalizability of the findings. Firstly, although we observed the highest risk of HSV-2 infection among former drinkers, this finding is based on the assumption that most of them were heavy drinkers before they quit. However, the NHANES dataset lacks specific data regarding the average daily alcohol consumption of former drinkers prior to cessation. This limitation restricts our ability to fully understand their previous drinking habits and its potential impact on the risk of HSV-2 infection. Secondly, despite utilizing regression models and stratified analyses to mitigate the effects of confounding variables, the potential for residual confounding from unmeasured or unknown factors cannot be entirely eliminated. This limitation underscores the need for cautious interpretation of the associations observed, as other unaccounted variables might influence the outcomes. Thirdly, our findings, based on a survey of U.S. adults, may not be generalizable to other populations without further investigation. Cultural, social, and behavioral differences in various populations might affect the relationship between alcohol consumption and HSV-2, thus limiting the universality of our results. Lastly, the inherent limitations of cross-sectional studies constrain our ability to establish a causal relationship between alcohol consumption and HSV-2 infection. Longitudinal studies are required to confirm these findings and to explore the temporal sequence between alcohol consumption and HSV-2 infection. Moreover, although our study focuses on the association between alcohol consumption and HSV-2, other lifestyle factors such as smoking also play a significant role in HSV-2 infection and warrant further exploration to fully understand the multifactorial nature of this health issue.

5. Conclusion

In conclusion, there is an association between alcohol consumption and HSV-2 infection among adult populations in the United States. The results of this study have drawn attention to the link between lifestyle factors, particularly alcohol consumption, and HSV-2 infection.

Supporting information

S1 File

(DOCX)

pone.0307702.s001.docx (3.8MB, docx)

Acknowledgments

Thanks to Zhang Jing (Second Department of Infectious Disease, Shanghai Fifth People’s Hospital, Fudan University) for his work on the NHANES database.

Abbreviations

AChR

α-acetylcholine receptors

BMI

Body Mass Index

CI

Confidence interval

EBV

Epstein-Barr virus

HbA1c

Glycated hemoglobin

HIV

Human immunodeficiency virus

HSV

Herpes Simplex Virus

NCHS

National Center for Health Statistics

NHANES

National Health and Nutrition Examination Survey

OR

Odds ratio

PSM

Propensity score matching

SD

Standard deviation

Std diff

Standardized difference

Data Availability

All data are available from https://www.cdc.gov/nchs/nhanes/index.htm.

Funding Statement

This study was supported by National Natural Science Foundation of China (882172520), Soochow University High-End Platform and Translational Base Construction Project for Clinical Medicine Science and Technology.

References

  • 1.Silva S, Ayoub HH, Johnston C, Atun R, Abu-Raddad LJ. Estimated economic burden of genital herpes and HIV attributable to herpes simplex virus type 2 infections in 90 low- and middle-income countries: A modeling study. PLoS Med. 2022;19: e1003938. doi: 10.1371/journal.pmed.1003938 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Looker KJ, Garnett GP, Schmid GP. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Organ. 2008;86: 805–812, A. doi: 10.2471/blt.07.046128 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.AlMukdad S, Harfouche M, Wettstein A, Abu-Raddad LJ. Epidemiology of herpes simplex virus type 2 in Asia: A systematic review, meta-analysis, and meta-regression. Lancet Reg Health West Pac. 2021;12: 100176. doi: 10.1016/j.lanwpc.2021.100176 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Johnston C. Diagnosis and Management of Genital Herpes: Key Questions and Review of the Evidence for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines. Clin Infect Dis Off Publ Infect Dis Soc Am. 2022;74: S134–S143. doi: 10.1093/cid/ciab1056 [DOI] [PubMed] [Google Scholar]
  • 5.Peacock A, Leung J, Larney S, Colledge S, Hickman M, Rehm J, et al. Global statistics on alcohol, tobacco and illicit drug use: 2017 status report. Addict Abingdon Engl. 2018;113: 1905–1926. doi: 10.1111/add.14234 [DOI] [PubMed] [Google Scholar]
  • 6.Jiang M, Tang X, Wang P, Yang L, Du R. Association between daily alcohol consumption and serum alpha klotho levels among U.S. adults over 40 years old: a cross-sectional study. BMC Public Health. 2023;23: 1901. doi: 10.1186/s12889-023-16830-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019;13: S31–S34. doi: 10.4103/sja.SJA_543_18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Rattan P, Penrice DD, Ahn JC, Ferrer A, Patnaik M, Shah VH, et al. Inverse Association of Telomere Length With Liver Disease and Mortality in the US Population. Hepatol Commun. 2022;6: 399–410. doi: 10.1002/hep4.1803 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Hicks CW, Wang D, Matsushita K, Windham BG, Selvin E. Peripheral Neuropathy and All-Cause and Cardiovascular Mortality in U.S. Adults: A Prospective Cohort Study. Ann Intern Med. 2021;174: 167–174. doi: 10.7326/M20-1340 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Golabi P, Paik JM, Harring M, Younossi E, Kabbara K, Younossi ZM. Prevalence of High and Moderate Risk Nonalcoholic Fatty Liver Disease Among Adults in the United States, 1999–2016. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2022;20: 2838–2847.e7. doi: 10.1016/j.cgh.2021.12.015 [DOI] [PubMed] [Google Scholar]
  • 11.Whelton PK, Carey RM. The 2017 American College of Cardiology/American Heart Association Clinical Practice Guideline for High Blood Pressure in Adults. JAMA Cardiol. 2018;3: 352–353. doi: 10.1001/jamacardio.2018.0005 [DOI] [PubMed] [Google Scholar]
  • 12.Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int. 2021;100: S1–S276. doi: 10.1016/j.kint.2021.05.021 [DOI] [PubMed] [Google Scholar]
  • 13.Mirza S, Clay RD, Koslow MA, Scanlon PD. COPD Guidelines: A Review of the 2018 GOLD Report. Mayo Clin Proc. 2018;93: 1488–1502. doi: 10.1016/j.mayocp.2018.05.026 [DOI] [PubMed] [Google Scholar]
  • 14.Ao TTH, Sam NE, Masenga EJ, Seage GR, Kapiga SH. Human immunodeficiency virus type 1 among bar and hotel workers in northern Tanzania: the role of alcohol, sexual behavior, and herpes simplex virus type 2. Sex Transm Dis. 2006;33: 163–169. doi: 10.1097/01.olq.0000187204.57006.b3 [DOI] [PubMed] [Google Scholar]
  • 15.Doi Y, Ninomiya T, Hata J, Yonemoto K, Tanizaki Y, Arima H, et al. Seroprevalence of herpes simplex virus 1 and 2 in a population-based cohort in Japan. J Epidemiol. 2009;19: 56–62. doi: 10.2188/jea.je20080061 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Fisher JC, Cook PA, Sam NE, Kapiga SH. Patterns of alcohol use, problem drinking, and HIV infection among high-risk African women. Sex Transm Dis. 2008;35: 537–544. doi: 10.1097/OLQ.0b013e3181677547 [DOI] [PubMed] [Google Scholar]
  • 17.Rosenberg M, Pettifor A, Van Rie A, Thirumurthy H, Emch M, Miller WC, et al. The Relationship between Alcohol Outlets, HIV Risk Behavior, and HSV-2 Infection among South African Young Women: A Cross-Sectional Study. PloS One. 2015;10: e0125510. doi: 10.1371/journal.pone.0125510 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Hu X, Zhang T, Ma H, Zhou X, Wang H, Wang X, et al. Repetitive transcranial magnetic stimulation combined with cognitive behavioral therapy treatment in alcohol-dependent patients: A randomized, double-blind sham-controlled multicenter clinical trial. Front Psychiatry. 2022;13: 935491. doi: 10.3389/fpsyt.2022.935491 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Spataru A, Le Duc D, Zagrean L, Zagrean A-M. Ethanol exposed maturing rat cerebellar granule cells show impaired energy metabolism and increased cell death after oxygen-glucose deprivation. Neural Regen Res. 2019;14: 485–490. doi: 10.4103/1673-5374.245474 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Lond Engl. 2018;392: 1015–1035. doi: 10.1016/S0140-6736(18)31310-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Hoyt LR, Ather JL, Randall MJ, DePuccio DP, Landry CC, Wewers MD, et al. Ethanol and Other Short-Chain Alcohols Inhibit NLRP3 Inflammasome Activation through Protein Tyrosine Phosphatase Stimulation. J Immunol Baltim Md 1950. 2016;197: 1322–1334. doi: 10.4049/jimmunol.1600406 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Lewis SA, Doratt BM, Qiao Q, Blanton M, Grant KA, Messaoudi I. Integrated single cell analysis shows chronic alcohol drinking disrupts monocyte differentiation in the bone marrow. Stem Cell Rep. 2023;18: 1884–1897. doi: 10.1016/j.stemcr.2023.08.001 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Tinashe Mudzviti

24 May 2024

PONE-D-24-11862

The association between alcohol consumption and Herpes simplex virus type 2: A cross-sectional study from National Health and Nutrition Examination Survey 2009-2016

PLOS ONE

Dear Dr. Shan,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jul 08 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Tinashe Mudzviti, MPhil(MD)

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please note that funding information should not appear in any section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript.

3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. 

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

4. Thank you for stating the following in your Competing Interests section:  

   "no"

Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now 

 This information should be included in your cover letter; we will change the online submission form on your behalf.

5. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

6. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files

7. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

8. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thank you for taking the time to conduct this cross-sectional study. In the methods section, you categorized and defined alcohol consumption into five groups: non-drinkers, former drinkers, current light drinkers, current moderate drinkers, and heavy drinkers. Regarding the non-drinkers group, throughout the study, you use non-drinkers interchangeably with never-drinkers. However, the non-drinkers group is defined as those who “consumed less than 12 alcoholic beverages in their lifetime.” Should this be updated for consistency and accuracy across the study?

Reviewer #2: I would suggest the following minor revisions to improve the clarity, precision, and overall quality of the manuscript:

Clarification of Terminology: Ensure that all terms, especially those related to alcohol consumption categories, are clearly defined and consistent throughout the manuscript.

Expansion on Limitations: While the authors have mentioned the limitations, it would be beneficial to expand on how these limitations might impact the interpretation of the results and what that means for the generalizability of the findings.

Additional Subgroup Analysis: Consider including additional subgroup analyses based on other potential confounders such as socioeconomic status or geographic location to further explore the heterogeneity of the results.

Strengthening the Discussion: The discussion section could be strengthened by incorporating a more detailed comparison with existing literature, especially regarding the biological mechanisms by which alcohol consumption might increase the risk of HSV-2 infection.

Statistical Methodology: Provide more detail on the statistical methods used, particularly regarding the adjustments made in the logistic regression models and the rationale behind the choice of these adjustments.

Consistency in Data Presentation: Ensure that tables and figures are consistent with the text and that they are clearly and accurately referenced within the manuscript.

Reference Updates: Check the references for the most current and relevant literature to support the study's findings and arguments.

Language and Grammar: While the manuscript is generally well-written, there may be minor grammatical errors or awkward phrasings that could be polished for better readability.

Confirmation of Ethical Compliance: If applicable, provide a statement confirming that the study complies with ethical standards regarding the protection of personal data and privacy of participants.

These minor revisions would help to enhance the manuscript's contribution to the field and ensure that it meets the high standards of the journal.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Jul 24;19(7):e0307702. doi: 10.1371/journal.pone.0307702.r002

Author response to Decision Letter 0


21 Jun 2024

Response Letter

Dear Editor Tinashe Mudzviti,

On behalf of my co-authors, I greatly appreciate the careful review and insightful comments from the editor and the reviewers. We believe that by implementing the suggested changes, we now have a stronger manuscript entitled "The Association Between Alcohol Consumption and Herpes Simplex Virus Type 2: A Cross-Sectional Study from the National Health and Nutrition Examination Survey 2009-2016" (ID: PONE-D-24-11862) ready for submission to PLOS ONE. We look forward to your positive response to the revised work submitted here.

We present here point-to-point responses for each of the comments in the attached document and have revised our manuscript accordingly. We hope the revised manuscript will be acceptable.

Editors' and reviewers' comments are given in bold, and specific points of advice have been numbered. Revised sections are identified with blue text in the manuscript.

There are no conflicts of interest regarding this work. All authors have read the revised manuscript and approved its submission to PLOS ONE. Please do not hesitate to contact us if further assistance is needed.

Thank you and best regards.

Yours Sincerely,

Yushan Shi

Manuscript ID number:

PONE-D-24-11862

Title of paper:

The Association Between Alcohol Consumption and Herpes Simplex Virus Type 2: A Cross-Sectional Study from the National Health and Nutrition Examination Survey 2009-2016

Reply to Editor:

We have uploaded the three required documents: 'Response to Reviewers,' 'Revised Manuscript with Track Changes,' and the 'Manuscript' itself, in accordance with your guidelines. There is no need to amend the financial disclosure. We have resubmitted the figure files following the journal’s specifications. Our study does not require the submission of laboratory protocols.

Point-to-Point Responses

1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming.

Response:

We have revised our manuscript according to the PLOS ONE style templates provided on your website. This ensures that our submission meets all PLOS ONE style requirements, including those pertaining to file naming.

2.Please note that funding information should not appear in any section or other areas of your manuscript.

Response:

Thank you for your reminder. We have removed the related information from the manuscript as per your request.

3.We note that the grant information you provided in the "Funding Information" and "Financial Disclosure" sections do not match. 

Response:

Thank you for your reminder. In the resubmitted manuscript, we have provided the accurate and final funding information.

4.Please complete your Competing Interests on the online submission form to state any Competing Interests.

Response:

We have indicated in our manuscript that "The authors have declared that no competing interests exist." We appreciate and agree to your updating the online submission form on our behalf.

5.Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. 

Response:

Thank you for your guidance. We completed the process by updating our information and authenticating the ORCID iD as instructed.

6.Please include your tables as part of your main manuscript and remove the individual files.

Response:

We have removed the individual table files and included them as part of the main manuscript. Supplementary tables have been uploaded as separate "supporting information" files, as instructed.

7.Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly.

Response:

We have added captions for the Supporting Information files at the end of our manuscript and updated the in-text citations accordingly.

8.Please review your reference list to ensure that it is complete and correct. 

Response:

We have reviewed our reference list and confirm that it does not include any retracted papers. Based on the reviewers' suggestions, we have added several relevant references. These additions have been highlighted in blue text in the 'Revised Manuscript with Track Changes.'

Request: Due to the recent job transition of the first author, we regretfully request to add another new affiliation in the author information. Please refer to line 7 for specific details.

Reply to Reviewer 1:

Dear Reviewer,

Thank you very much for taking the time to review our manuscript and for your constructive comments and valuable suggestions, which have greatly assisted in enhancing the quality of our work. We have carefully revised the manuscript in accordance with your feedback, thoroughly proofread the text, rephrased paragraphs, and corrected any inaccuracies.

We hope that these revisions will meet your approval, and we look forward to your acceptance of the amended manuscript.

1.In the methods section, you categorized and defined alcohol consumption into five groups: non-drinkers, former drinkers, current light drinkers, current moderate drinkers, and heavy drinkers. Regarding the non-drinkers group, throughout the study, you use non-drinkers interchangeably with never drinker. However, the non-drinkers group is defined as those who "consumed less than 12 alcoholic beverages in their lifetime." Should this be updated for consistency and accuracy across the study?

Response:

Thank you for your insightful comment regarding the classification of non-drinkers in our study. We have carefully reviewed the terminology used throughout the manuscript and have now standardized the term to "never drinkers" consistently across the text. This change clarifies our definition and aligns with your suggestion for accuracy and consistency. We appreciate your attention to detail and guidance, which have significantly improved the manuscript.

Reply to Reviewer 2:

Dear Reviewer,

Thank you very much for taking the time to review our manuscript. We are particularly grateful for your suggestions regarding Clarification of Terminology, Expansion on Limitations, Additional Subgroup Analysis, Strengthening the Discussion, Statistical Methodology, Consistency in Data Presentation, Reference Updates, Language and Grammar, and Confirmation of Ethical Compliance. Following your advice, we have thoroughly revised the manuscript. This includes standardizing terminology, thoroughly discussing limitations, adding subgroup analyses, and addressing the other issues you raised.

We hope that the revised manuscript meets your approval, and we look forward to your acceptance.

1.Clarification of Terminology: Ensure that all terms, especially those related to alcohol consumption categories, are clearly defined and consistent throughout the manuscript.

Response:

Thank you for your constructive feedback. We have categorized and defined alcohol consumption into five groups: never drinkers, former drinkers, light drinkers, moderate drinkers, and heavy drinkers. We have carefully reviewed the terminology used throughout the manuscript to ensure that these five terms are standardized and consistently applied. This revision clarifies our definitions and aligns with your recommendations for accuracy and consistency. We appreciate your attention to detail and guidance, which have significantly enhanced the manuscript.

2.Expansion on Limitations: While the authors have mentioned the limitations, it would be beneficial to expand on how these limitations might impact the interpretation of the results and what that means for the generalizability of the findings.

Response:

Thank you for your suggestion. In response to your request, we have revised and, in fact, essentially rewritten the Limitations section of our manuscript. The new Limitations section has been expanded to include a detailed analysis of how each limitation might affect the interpretation of our results and their generalizability. The revised content is highlighted in blue in the manuscript.

Line 265-284:Our study is subject to several limitations that warrant consideration, which may affect the interpretation and generalizability of the findings. Firstly, although we observed the highest risk of HSV-2 infection among former drinkers, this finding is based on the assumption that most of them were heavy drinkers before they quit. However, the NHANES dataset lacks specific data regarding the average daily alcohol consumption of former drinkers prior to cessation. This limitation restricts our ability to fully understand their previous drinking habits and its potential impact on the risk of HSV-2 infection. Secondly, despite utilizing regression models and stratified analyses to mitigate the effects of confounding variables, the potential for residual confounding from unmeasured or unknown factors cannot be entirely eliminated. This limitation underscores the need for cautious interpretation of the associations observed, as other unaccounted variables might influence the outcomes. Thirdly, our findings, based on a survey of U.S. adults, may not be generalizable to other populations without further investigation. Cultural, social, and behavioral differences in various populations might affect the relationship between alcohol consumption and HSV-2, thus limiting the universality of our results. Lastly, the inherent limitations of cross-sectional studies constrain our ability to establish a causal relationship between alcohol consumption and HSV-2 infection. Longitudinal studies are required to confirm these findings and to explore the temporal sequence between alcohol consumption and HSV-2 infection. Moreover, although our study focuses on the association between alcohol consumption and HSV-2, other lifestyle factors such as smoking also play a significant role in HSV-2 infection and warrant further exploration to fully understand the multifactorial nature of this health issue.

3.Additional Subgroup Analysis: Consider including additional subgroup analyses based on other potential confounders such as socioeconomic status or geographic location to further explore the heterogeneity of the results.

Response:

Thank you for your suggestion. We have already included 'family income' as a variable in our existing subgroup analyses, as shown in Figure 2. Based on the variables available in our baseline data, we have incorporated additional potential confounders into our subgroup analyses, including race, educational level, BMI, insurance status, smoking status, frequency of condom use, and conditions such as CKD, COPD, CVD, and cancer. There were no interaction effects within these subgroups; the association between alcohol consumption and HSV-2 infection remained consistent across all. The results of these new subgroup analyses have been uploaded as a supplementary file named "Supplementary Figure 1."

Supplementary Figure 1 The relationship between alcohol consumption and HSV-2 in various subgroups

4.Strengthening the Discussion: The discussion section could be strengthened by incorporating a more detailed comparison with existing literature, especially regarding the biological mechanisms by which alcohol consumption might increase the risk of HSV-2 infection.

Response:

Thank you for your suggestion. We have further enhanced the discussion section by conducting a more detailed comparison with existing literature on the topic and introducing new references (citation 22). Specifically, we have expanded our discussion to include an in-depth analysis of the biological mechanisms through which alcohol consumption may increase the risk of HSV-2 infection. This includes an examination of how alcohol impairs immune function, influences behaviors that increase infection risk, and potentially exacerbates the viral replication process. We believe that these additions will provide a comprehensive understanding of the interaction between alcohol consumption and HSV-2 infection, aligning our findings with established research in the field.

Line 244-253:Moreover, studies have shown that chronic alcohol consumption can alter the transcriptome of bone marrow-derived monocytes, potentially impacting monocyte activity and their migration from the bone marrow, thereby affecting immune responses. Additionally, chronic alcohol intake can bias the differentiation of CD34+ progenitor cells in the bone marrow towards the granulocyte/monocyte lineage, leading to a decreased antigen-presenting capability of monocytes derived from CD34+ progenitor cells[22]. This alteration persists even after cessation of alcohol consumption and may compromise both immune and inflammatory responses. These impacts on the immune system and inflammatory responses could increase susceptibility to HSV-2, also explaining why former drinkers may still exhibit a heightened risk of HSV-2 infection.

5.Consistency in Data Presentation: Ensure that tables and figures are consistent with the text and that they are clearly and accurately referenced within the manuscript.

Response:

Thank you for your suggestion. We have carefully reviewed the description of table data and results section, removed redundant content, ensuring that the data in the tables can be clearly and accurately referenced within the manuscript.

Reference Updates: Check the references for the most current and relevant literature to support the study's findings and arguments.

Response:

Thank you for your suggestion. We have carefully checked for the most recent and relevant literature and have added a reference published in 2023 (citation 22) to further support our study's findings and arguments.

6.Language and Grammar: While the manuscript is generally well-written, there may be minor grammatical errors or awkward phrasings that could be polished for better readability.

Response:

Thank you for your constructive feedback on the language quality of our manuscript. We fully acknowledge that being non-native English speakers does not justify the language issues. In response to your feedback, we have made every effort to improve the clarity and readability of our text. We have received assistance from a native English speaker from the United States to thoroughly improve our article. We hope that these revisions meet your expectations.

7.Confirmation of Ethical Compliance: If applicable, provide a statement confirming that the study complies with ethical standards regarding the protection of personal data and privacy of participants.

Response:

Thank you for your suggestion. We have provided a statement confirming that the study complies with ethical standards regarding the protection of personal data and privacy of participants. The confirmation document is attached and is named "Ethical Statement."

Attachment

Submitted filename: Response to Reviewers.docx

pone.0307702.s002.docx (736.2KB, docx)

Decision Letter 1

Tinashe Mudzviti

10 Jul 2024

The association between alcohol consumption and Herpes simplex virus type 2: A cross-sectional study from National Health and Nutrition Examination Survey 2009-2016

PONE-D-24-11862R1

Dear Dr. Shan,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Tinashe Mudzviti, MPhil(MD)

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Tinashe Mudzviti

15 Jul 2024

PONE-D-24-11862R1

PLOS ONE

Dear Dr. Shan,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Tinashe Mudzviti

Academic Editor

PLOS ONE


Articles from PLOS ONE are provided here courtesy of PLOS

RESOURCES